Sort   by:  
 Page size 
UnknownFirst-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Not available
S-EPMC10155215 | biostudies-literature
UnknownEffects of Multilevel and Multidomain Interventions on Glycemic Control in U.S. Hispanic Populations.
Not available
S-EPMC12469673 | biostudies-literature
UnknownThe Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
Not available
S-EPMC8810987 | biostudies-literature
UnknownLonger-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis.
Not available
S-EPMC8811049 | biostudies-literature
UnknownLow-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Not available
S-EPMC6587584 | biostudies-literature
Sort   by:  
 Page size